Pharmacokinetics and Tolerability of Oral Semaglutide in Subjects with Renal Impairment

被引：0
|
作者：
Granhall, Charlotte
Rethy, Agnes
Sondergaard, Flemming L.
Thomsen, Mette
Anderson, Thomas W.
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1189-P
引用
收藏
页码：A317 / A318
页数：2
相关论文
共 50 条
  • [21] Abstracts of the 53rd Annual Meeting of the EASD, Lisbon 2017. Abstract 788: 'Pharmacokinetics and tolerability of oral semaglutide in subjects with renal impairment' (vol 60, pg 609, 2017)
    Anderson, T. W.
    Granhall, C.
    Rethy, A.
    Sondergaard, F. L.
    Thomsen, M.
    DIABETOLOGIA, 2017, 60 : 609 - 609
  • [22] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF SELADELPAR IN SUBJECTS WITH HEPATIC IMPAIRMENT
    Mao, Z.
    Martin, Robert
    Steinberg, Alexandra
    Rohane, Patricia
    Nguyen, Jaidyn
    Standen, Mary
    Boudes, Pol
    GASTROENTEROLOGY, 2019, 156 (06) : S1320 - S1320
  • [23] Pharmacokinetics, safety, and tolerability of seladelpar in subjects with hepatic impairment
    Mao, Lily
    Martin, Robert
    Steinberg, Alexandra
    Rohane, Patricia
    Nguyen, Jaidyn
    Standen, Mary
    Boudes, Pol
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E402 - E402
  • [24] Pharmacokinetics of Teneligliptin in Subjects With Renal Impairment
    Halabi, Atef
    Maatouk, Haidar
    Siegler, Karl Ernst
    Faisst, Nadja
    Lufft, Volkmar
    Klause, Norbert
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (03): : 246 - 254
  • [25] Garenoxacin pharmacokinetics in subjects with renal impairment
    Krishna, Gopal
    Gajjar, Diptee
    Swan, Suzanne
    Marbury, Thomas
    Grasela, Dennis M.
    Wang, Zaiqi
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (03) : 649 - 657
  • [26] Pharmacokinetics of repaglinide in subjects with renal impairment
    Marbury, TC
    Ruckle, JL
    Hatorp, V
    Andersen, MP
    Nielsen, KK
    Huang, WC
    Strange, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (01) : 7 - 15
  • [27] Pharmacokinetics of teduglutide in subjects with renal impairment
    Nave, Ruediger
    Halabi, Atef
    Herzog, Rolf
    Schaffer, Peter
    Diefenbach, Joerg
    Krause, Stephan
    Berghoefer, Peter
    Lahu, Gezim
    Hartmann, Manfred
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (05) : 1149 - 1155
  • [28] Pharmacokinetics of teduglutide in subjects with renal impairment
    Rüdiger Nave
    Atef Halabi
    Rolf Herzog
    Peter Schaffer
    Jörg Diefenbach
    Stephan Krause
    Peter Berghöfer
    Gezim Lahu
    Manfred Hartmann
    European Journal of Clinical Pharmacology, 2013, 69 : 1149 - 1155
  • [29] Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis
    Grasela, DM
    Stoltz, RR
    Barry, M
    Bone, M
    Mangold, B
    O'Grady, P
    Raymond, R
    Haworth, SJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) : 2149 - 2153
  • [30] Effect of Renal Impairment on the Pharmacokinetics and Safety of Rivipansel in Subjects with Renal Impairment and in Healthy Subjects
    Tammara, Brinda
    Ryan, Kelly
    Plotka, Anna
    Shafer, Frank E.
    Wei, Hua
    Readett, David
    Fang, Annie
    Korth-Bradley, Joan
    BLOOD, 2018, 132
12345